|
STK39 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.91810020591754E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.75699996166168E-09 |
| Normal-vs-Stage2 |
4.449500E-02 |
| Normal-vs-Stage3 |
2.158700E-04 |
| Normal-vs-Stage4 |
1.786770E-04 |
| Stage1-vs-Stage2 |
9.616100E-02 |
| Stage1-vs-Stage3 |
8.427400E-01 |
| Stage1-vs-Stage4 |
3.012200E-01 |
| Stage2-vs-Stage3 |
1.687230E-01 |
| Stage2-vs-Stage4 |
3.951800E-02 |
| Stage3-vs-Stage4 |
3.495800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.00379998652289E-09 |
| Normal-vs-AfricanAmerican |
1.964100E-02 |
| Normal-vs-Asian |
6.823800E-03 |
| Caucasian-vs-AfricanAmerican |
3.628000E-01 |
| Caucasian-vs-Asian |
7.325200E-01 |
| AfricanAmerican-vs-Asian |
5.200800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.7155000000546E-06 |
| Normal-vs-Female |
2.12719997172428E-09 |
| Male-vs-Female |
8.582800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.31320000324098E-08 |
| Normal-vs-Age(41-60Yrs) |
1.94785999999558E-05 |
| Normal-vs-Age(61-80Yrs) |
1.973490E-04 |
| Normal-vs-Age(81-100Yrs) |
3.223900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.087000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.188200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.764400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.637600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.860590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.157900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.487600E-01 |
| Classical-VS-Follicular |
8.172900E-04 |
| Classical-VS-Other |
1.594350E-01 |
| Classical-VS-Normal |
6.87061518789278E-12 |
| Tall-VS-Follicular |
8.401000E-03 |
| Tall-VS-Other |
9.045600E-02 |
| Tall-VS-Normal |
2.969900E-04 |
| Follicular-VS-Other |
7.442000E-01 |
| Follicular-VS-Normal |
1.003750E-01 |
| Other-VS-Normal |
7.717600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.982500E-04 |
| Normal-vs-N1 |
3.818500E-04 |
| N0-vs-N1 |
6.589900E-02 |
|
|
